MicroRNA in human cancer and chronic inflammatory diseases

Jagat R Kanwar1, Ganesh Mahidhara, Rupinder K Kanwar

  • 1Laboratory of Immunology and Molecular Biomedical Research, Centre for Biotechnology and Interdisciplinary Biosciences (BioDeakin), Institute for Technology and Research Innovation , Geelong Technology Precinct, Deakin University, Pigdons Road, Waurn Ponds, Geelong, Victoria 3217, Australia. jagat.kanwar@deakin.edu.au

Insights

MicroRNAs (miRNAs) are key gene regulators implicated in various diseases. Their differential expression offers potential for developing novel diagnostics and therapeutics for conditions like cancer and neurodegenerative disorders.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • MicroRNAs (miRNAs) are non-coding RNAs regulating gene expression post-translationally.
  • miRNAs play crucial roles in cellular and developmental processes.
  • Specific miRNA expression patterns are associated with distinct tissue types.

Purpose of the Study:

  • To review differentially expressed miRNAs in human diseases.
  • To explore the role of miRNAs as tumor suppressors and oncogenes.
  • To discuss the prospective development of miRNA-based diagnostics and therapeutics.

Main Methods:

  • Literature review of studies on miRNA expression in diseases.
  • Analysis of miRNA roles in cancer, neurodegenerative, and inflammatory diseases.
  • Synthesis of findings on miRNA deregulation and its implications.

Main Results:

  • Differential miRNA expression is observed across various human diseases, including cancers and neurodegenerative conditions.
  • miRNAs can function as both tumor suppressors and oncogenes, contributing to disease development.
  • Altered miRNA profiles are linked to chronic inflammatory and metabolic diseases.

Conclusions:

  • miRNA deregulation is a significant factor in human disease pathogenesis.
  • miRNAs hold promise as biomarkers for disease diagnosis.
  • Targeting miRNAs presents a potential therapeutic strategy for various human malignancies and other diseases.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...